Updated efficacy and safety data from the AETHERA trial of consolidation with brentuximab vedotin after autologous stem cell transplant (ASCT) in Hodgkin lymphoma patients at high risk of relapse Meeting Abstract


Authors: Sweetenham, J. W.; Walewski, J.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. L.; Stiff, P.; Viviani, S.; Carella, A.; Osmanov, D.; Bachanova, V.; Sureda, A.; Huebner, D.; Larsen, E. K.; Hunder, N. N.; Moskowitz, C. H.
Abstract Title: Updated efficacy and safety data from the AETHERA trial of consolidation with brentuximab vedotin after autologous stem cell transplant (ASCT) in Hodgkin lymphoma patients at high risk of relapse
Meeting Title: 2016 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 22
Issue: 3 Suppl. 1
Meeting Dates: 2016 Feb 18-22
Meeting Location: Honolulu, HI
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2016-03-01
Start Page: S36
End Page: S37
Language: English
ACCESSION: WOS:000370910300028
PROVIDER: wos
DOI: 10.1016/j.bbmt.2015.11.315
Notes: Meeting Abstract: 23 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz